請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35983完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 張?仁(Ching-Jin Chang) | |
| dc.contributor.author | Ya-Ling Huang | en |
| dc.contributor.author | 黃雅聆 | zh_TW |
| dc.date.accessioned | 2021-06-13T07:49:08Z | - |
| dc.date.available | 2005-07-27 | |
| dc.date.copyright | 2005-07-27 | |
| dc.date.issued | 2005 | |
| dc.date.submitted | 2005-07-25 | |
| dc.identifier.citation | 參考文獻
Alonso, G., Ambrosino, C., Jones, M. and Nebreda, A.R. (2000) Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength. J Biol Chem, 275, 40641-40648. Antic, D. and Keene, J.D. (1997) Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am J Hum Genet, 61, 273-278. Antic, D., Lu, N. and Keene, J.D. (1999) ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells. Genes Dev, 13, 449-461. Atasoy, U., Watson, J., Patel, D. and Keene, J.D. (1998) ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J Cell Sci, 111 (Pt 21), 3145-3156. Atwater, J.A., Wisdom, R. and Verma, I.M. (1990) Regulated mRNA stability. Annu Rev Genet, 24, 519-541. Bakheet, T., Frevel, M., Williams, B.R., Greer, W. and Khabar, K.S. (2001) ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res, 29, 246-254. Beutler, B. and Cerami, A. (1989) The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol, 7, 625-655. Blackshear, P.J. (2002) Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem Soc Trans, 30, 945-952. Blackshear, P.J., Lai, W.S., Kennington, E.A., Brewer, G., Wilson, G.M., Guan, X. and Zhou, P. (2003) Characteristics of the interaction of a synthetic human tristetraprolin tandem zinc finger peptide with AU-rich element-containing RNA substrates. J Biol Chem, 278, 19947-19955. Brennan, C.M. and Steitz, J.A. (2001) HuR and mRNA stability. Cell Mol Life Sci, 58, 266-277. Brewer, G. and Ross, J. (1988) Poly(A) shortening and degradation of the 3' A+U-rich sequences of human c-myc mRNA in a cell-free system. Mol Cell Biol, 8, 1697-1708. Brook, M., Sully, G., Clark, A.R. and Saklatvala, J. (2000) Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade. FEBS Lett, 483, 57-61. Brooks, S.A., Connolly, J.E., Diegel, R.J., Fava, R.A. and Rigby, W.F. (2002) Analysis of the function, expression, and subcellular distribution of human tristetraprolin. Arthritis Rheum, 46, 1362-1370. Brooks, S.A., Connolly, J.E. and Rigby, W.F. (2004) The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway. J Immunol, 172, 7263-7271. Campos, A.R., Grossman, D. and White, K. (1985) Mutant alleles at the locus elav in Drosophila melanogaster lead to nervous system defects. A developmental-genetic analysis. J Neurogenet, 2, 197-218. Camps, M., Nichols, A. and Arkinstall, S. (2000) Dual specificity phosphatases: a gene family for control of MAP kinase function. Faseb J, 14, 6-16. Carballo, E., Cao, H., Lai, W.S., Kennington, E.A., Campbell, D. and Blackshear, P.J. (2001) Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway. J Biol Chem, 276, 42580-42587. Carballo, E., Gilkeson, G.S. and Blackshear, P.J. (1997) Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNFalpha overproduction. J Clin Invest, 100, 986-995. Carballo, E., Lai, W.S. and Blackshear, P.J. (1998) Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science, 281, 1001-1005. Carballo, E., Lai, W.S. and Blackshear, P.J. (2000) Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood, 95, 1891-1899. Chang, L. and Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature, 410, 37-40. Chen, C.Y., Gherzi, R., Ong, S.E., Chan, E.L., Raijmakers, R., Pruijn, G.J., Stoecklin, G., Moroni, C., Mann, M. and Karin, M. (2001) AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell, 107, 451-464. Chen, C.Y. and Shyu, A.B. (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci, 20, 465-470. Chrestensen, C.A., Schroeder, M.J., Shabanowitz, J., Hunt, D.F., Pelo, J.W., Worthington, M.T. and Sturgill, T.W. (2004) MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem, 279, 10176-10184. Clark, A.R., Dean, J.L. and Saklatvala, J. (2003) Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Lett, 546, 37-44. Cok, S.J., Acton, S.J., Sexton, A.E. and Morrison, A.R. (2004) Identification of RNA-binding proteins in RAW 264.7 cells that recognize a lipopolysaccharide-responsive element in the 3-untranslated region of the murine cyclooxygenase-2 mRNA. J Biol Chem, 279, 8196-8205. Cuenda, A., Cohen, P., Buee-Scherrer, V. and Goedert, M. (1997) Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). Embo J, 16, 295-305. De, J., Lai, W.S., Thorn, J.M., Goldsworthy, S.M., Liu, X., Blackwell, T.K. and Blackshear, P.J. (1999) Identification of four CCCH zinc finger proteins in Xenopus, including a novel vertebrate protein with four zinc fingers and severely restricted expression. Gene, 228, 133-145. Dean, J.L., Brook, M., Clark, A.R. and Saklatvala, J. (1999) p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem, 274, 264-269. Dean, J.L., Sarsfield, S.J., Tsounakou, E. and Saklatvala, J. (2003) p38 Mitogen-activated protein kinase stabilizes mRNAs that contain cyclooxygenase-2 and tumor necrosis factor AU-rich elements by inhibiting deadenylation. J Biol Chem, 278, 39470-39476. Dean, J.L., Wait, R., Mahtani, K.R., Sully, G., Clark, A.R. and Saklatvala, J. (2001) The 3' untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol Cell Biol, 21, 721-730. Derijard, B., Raingeaud, J., Barrett, T., Wu, I.H., Han, J., Ulevitch, R.J. and Davis, R.J. (1995) Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science, 267, 682-685. Doza, Y.N., Cuenda, A., Thomas, G.M., Cohen, P. and Nebreda, A.R. (1995) Activation of the MAP kinase homologue RK requires the phosphorylation of Thr-180 and Tyr-182 and both residues are phosphorylated in chemically stressed KB cells. FEBS Lett, 364, 223-228. DuBois, R.N., McLane, M.W., Ryder, K., Lau, L.F. and Nathans, D. (1990) A growth factor-inducible nuclear protein with a novel cysteine/histidine repetitive sequence. J Biol Chem, 265, 19185-19191. Engelman, J.A., Lisanti, M.P. and Scherer, P.E. (1998) Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem, 273, 32111-32120. Enslen, H., Raingeaud, J. and Davis, R.J. (1998) Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem, 273, 1741-1748. Fairhurst, A.M., Connolly, J.E., Hintz, K.A., Goulding, N.J., Rassias, A.J., Yeager, M.P., Rigby, W. and Wallace, P.K. (2003) Regulation and localization of endogenous human tristetraprolin. Arthritis Res Ther, 5, R214-225. Fan, X.C. and Steitz, J.A. (1998) HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc Natl Acad Sci U S A, 95, 15293-15298. Fan, X.C. and Steitz, J.A. (1998) Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. Embo J, 17, 3448-3460. Figueroa, A., Cuadrado, A., Fan, J., Atasoy, U., Muscat, G.E., Munoz-Canoves, P., Gorospe, M. and Munoz, A. (2003) Role of HuR in skeletal myogenesis through coordinate regulation of muscle differentiation genes. Mol Cell Biol, 23, 4991-5004. Frevel, M.A., Bakheet, T., Silva, A.M., Hissong, J.G., Khabar, K.S. and Williams, B.R. (2003) p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol Cell Biol, 23, 425-436. Gallouzi, I.E., Brennan, C.M. and Steitz, J.A. (2001) Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock. Rna, 7, 1348-1361. Gallouzi, I.E., Brennan, C.M., Stenberg, M.G., Swanson, M.S., Eversole, A., Maizels, N. and Steitz, J.A. (2000) HuR binding to cytoplasmic mRNA is perturbed by heat shock. Proc Natl Acad Sci U S A, 97, 3073-3078. Gallouzi, I.E. and Steitz, J.A. (2001) Delineation of mRNA export pathways by the use of cell-permeable peptides. Science, 294, 1895-1901. Gao, M., Fritz, D.T., Ford, L.P. and Wilusz, J. (2000) Interaction between a poly(A)-specific ribonuclease and the 5' cap influences mRNA deadenylation rates in vitro. Mol Cell, 5, 479-488. Garcia, J., Lemercier, B., Roman-Roman, S. and Rawadi, G. (1998) A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1 and NF-kappaB activity and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways. J Biol Chem, 273, 34391-34398. Garrington, T.P. and Johnson, G.L. (1999) Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol, 11, 211-218. Ge, B., Gram, H., Di Padova, F., Huang, B., New, L., Ulevitch, R.J., Luo, Y. and Han, J. (2002) MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science, 295, 1291-1294. Goedert, M., Cuenda, A., Craxton, M., Jakes, R. and Cohen, P. (1997) Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases. Embo J, 16, 3563-3571. Good, P.J. (1995) A conserved family of elav-like genes in vertebrates. Proc Natl Acad Sci U S A, 92, 4557-4561. Gordon, S. (1998) The role of the macrophage in immune regulation. Res Immunol, 149, 685-688. Gueydan, C., Droogmans, L., Chalon, P., Huez, G., Caput, D. and Kruys, V. (1999) Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA. J Biol Chem, 274, 2322-2326. Hamilton, T.A., Ohmori, Y. and Tebo, J. (2002) Regulation of chemokine expression by antiinflammatory cytokines. Immunol Res, 25, 229-245. Han, J., Lee, J.D., Bibbs, L. and Ulevitch, R.J. (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science, 265, 808-811. Han, J., Wang, X., Jiang, Y., Ulevitch, R.J. and Lin, S. (1997) Identification and characterization of a predominant isoform of human MKK3. FEBS Lett, 403, 19-22. Hashimoto, A., Okada, H., Jiang, A., Kurosaki, M., Greenberg, S., Clark, E.A. and Kurosaki, T. (1998) Involvement of guanosine triphosphatases and phospholipase C-gamma2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor. J Exp Med, 188, 1287-1295. Heximer, S.P. and Forsdyke, D.R. (1993) A human putative lymphocyte G0/G1 switch gene homologous to a rodent gene encoding a zinc-binding potential transcription factor. DNA Cell Biol, 12, 73-88. Holtmann, H., Winzen, R., Holland, P., Eickemeier, S., Hoffmann, E., Wallach, D., Malinin, N.L., Cooper, J.A., Resch, K. and Kracht, M. (1999) Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol, 19, 6742-6753. Huang, S., New, L., Pan, Z., Han, J. and Nemerow, G.R. (2000) Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity. J Biol Chem, 275, 12266-12272. Jiang, Y., Chen, C., Li, Z., Guo, W., Gegner, J.A., Lin, S. and Han, J. (1996) Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J Biol Chem, 271, 17920-17926. Jiang, Y., Gram, H., Zhao, M., New, L., Gu, J., Feng, L., Di Padova, F., Ulevitch, R.J. and Han, J. (1997) Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J Biol Chem, 272, 30122-30128. Keene, J.D. (1999) Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc Natl Acad Sci U S A, 96, 5-7. Keyse, S.M. (2000) Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol, 12, 186-192. Kim, H.S., Armstrong, D., Hamilton, T.A. and Tebo, J.M. (1998) IL-10 suppresses LPS-induced KC mRNA expression via a translation-dependent decrease in mRNA stability. J Leukoc Biol, 64, 33-39. Kishore, R., Tebo, J.M., Kolosov, M. and Hamilton, T.A. (1999) Cutting edge: clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. J Immunol, 162, 2457-2461. Kontoyiannis, D., Pasparakis, M., Pizarro, T.T., Cominelli, F. and Kollias, G. (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity, 10, 387-398. Korner, C.G. and Wahle, E. (1997) Poly(A) tail shortening by a mammalian poly(A)-specific 3'-exoribonuclease. J Biol Chem, 272, 10448-10456. Kotlyarov, A., Neininger, A., Schubert, C., Eckert, R., Birchmeier, C., Volk, H.D. and Gaestel, M. (1999) MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol, 1, 94-97. Kotlyarov, A., Yannoni, Y., Fritz, S., Laass, K., Telliez, J.B., Pitman, D., Lin, L.L. and Gaestel, M. (2002) Distinct cellular functions of MK2. Mol Cell Biol, 22, 4827-4835. Kracht, M. and Saklatvala, J. (2002) Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine, 20, 91-106. Kullmann, M., Gopfert, U., Siewe, B. and Hengst, L. (2002) ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5'UTR. Genes Dev, 16, 3087-3099. Kumar, S., Boehm, J. and Lee, J.C. (2003) p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov, 2, 717-726. Kyriakis, J.M. and Avruch, J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev, 81, 807-869. Lai, W.S. and Blackshear, P.J. (2001) Interactions of CCCH zinc finger proteins with mRNA: tristetraprolin-mediated AU-rich element-dependent mRNA degradation can occur in the absence of a poly(A) tail. J Biol Chem, 276, 23144-23154. Lai, W.S., Carballo, E., Strum, J.R., Kennington, E.A., Phillips, R.S. and Blackshear, P.J. (1999) Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol, 19, 4311-4323. Lai, W.S., Carballo, E., Thorn, J.M., Kennington, E.A. and Blackshear, P.J. (2000) Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA. J Biol Chem, 275, 17827-17837. Lai, W.S., Kennington, E.A. and Blackshear, P.J. (2003) Tristetraprolin and its family members can promote the cell-free deadenylation of AU-rich element-containing mRNAs by poly(A) ribonuclease. Mol Cell Biol, 23, 3798-3812. Lai, W.S., Stumpo, D.J. and Blackshear, P.J. (1990) Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J Biol Chem, 265, 16556-16563. Lal, A., Mazan-Mamczarz, K., Kawai, T., Yang, X., Martindale, J.L. and Gorospe, M. (2004) Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. Embo J, 23, 3092-3102. Laroia, G., Cuesta, R., Brewer, G. and Schneider, R.J. (1999) Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science, 284, 499-502. Lasa, M., Mahtani, K.R., Finch, A., Brewer, G., Saklatvala, J. and Clark, A.R. (2000) Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol, 20, 4265-4274. Lechner, C., Zahalka, M.A., Giot, J.F., Moller, N.P. and Ullrich, A. (1996) ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci U S A, 93, 4355-4359. Lee, J.C., Laydon, J.T., McDonnell, P.C., Gallagher, T.F., Kumar, S., Green, D., McNulty, D., Blumenthal, M.J., Heys, J.R., Landvatter, S.W. and et al. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature, 372, 739-746. Lee, N.H. and Malek, R.L. (1998) Nerve growth factor regulation of m4 muscarinic receptor mRNA stability but not gene transcription requires mitogen-activated protein kinase activity. J Biol Chem, 273, 22317-22325. Levy, N.S., Chung, S., Furneaux, H. and Levy, A.P. (1998) Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem, 273, 6417-6423. Lewis, T., Gueydan, C., Huez, G., Toulme, J.J. and Kruys, V. (1998) Mapping of a minimal AU-rich sequence required for lipopolysaccharide-induced binding of a 55-kDa protein on tumor necrosis factor-alpha mRNA. J Biol Chem, 273, 13781-13786. Lin, A., Minden, A., Martinetto, H., Claret, F.X., Lange-Carter, C., Mercurio, F., Johnson, G.L. and Karin, M. (1995) Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science, 268, 286-290. Loflin, P., Chen, C.Y. and Shyu, A.B. (1999) Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev, 13, 1884-1897. Lykke-Andersen, J. and Wagner, E. (2005) Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev, 19, 351-361. Ma, Q. and Herschman, H.R. (1991) A corrected sequence for the predicted protein from the mitogen-inducible TIS11 primary response gene. Oncogene, 6, 1277-1278. Ma, Q., Wadleigh, D., Chi, T. and Herschman, H. (1994) The Drosophila TIS11 homologue encodes a developmentally controlled gene. Oncogene, 9, 3329-3334. Ma, W.J., Cheng, S., Campbell, C., Wright, A. and Furneaux, H. (1996) Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem, 271, 8144-8151. Ma, W.J., Chung, S. and Furneaux, H. (1997) The Elav-like proteins bind to AU-rich elements and to the poly(A) tail of mRNA. Nucleic Acids Res, 25, 3564-3569. Mahtani, K.R., Brook, M., Dean, J.L., Sully, G., Saklatvala, J. and Clark, A.R. (2001) Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol, 21, 6461-6469. Mazan-Mamczarz, K., Galban, S., Lopez de Silanes, I., Martindale, J.L., Atasoy, U., Keene, J.D. and Gorospe, M. (2003) RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci U S A, 100, 8354-8359. Medzhitov, R. and Janeway, C.A., Jr. (1998) Innate immune recognition and control of adaptive immune responses. Semin Immunol, 10, 351-353. Mertens, S., Craxton, M. and Goedert, M. (1996) SAP kinase-3, a new member of the family of mammalian stress-activated protein kinases. FEBS Lett, 383, 273-276. Min, H., Turck, C.W., Nikolic, J.M. and Black, D.L. (1997) A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. Genes Dev, 11, 1023-1036. Ming, X.F., Stoecklin, G., Lu, M., Looser, R. and Moroni, C. (2001) Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase. Mol Cell Biol, 21, 5778-5789. Mittelstadt, P.R. and DeFranco, A.L. (1993) Induction of early response genes by cross-linking membrane Ig on B lymphocytes. J Immunol, 150, 4822-4832. Miyazawa, K., Mori, A., Miyata, H., Akahane, M., Ajisawa, Y. and Okudaira, H. (1998) Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J Biol Chem, 273, 24832-24838. Moore, K.W., de Waal Malefyt, R., Coffman, R.L. and O'Garra, A. (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol, 19, 683-765. Mukherjee, D., Gao, M., O'Connor, J.P., Raijmakers, R., Pruijn, G., Lutz, C.S. and Wilusz, J. (2002) The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. Embo J, 21, 165-174. Myer, V.E., Fan, X.C. and Steitz, J.A. (1997) Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. Embo J, 16, 2130-2139. Neininger, A., Kontoyiannis, D., Kotlyarov, A., Winzen, R., Eckert, R., Volk, H.D., Holtmann, H., Kollias, G. and Gaestel, M. (2002) MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J Biol Chem, 277, 3065-3068. Ogawa, K., Chen, F., Kim, Y.J. and Chen, Y. (2003) Transcriptional regulation of tristetraprolin by transforming growth factor-beta in human T cells. J Biol Chem, 278, 30373-30381. Ono, K. and Han, J. (2000) The p38 signal transduction pathway: activation and function. Cell Signal, 12, 1-13. Pages, G., Berra, E., Milanini, J., Levy, A.P. and Pouyssegur, J. (2000) Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. J Biol Chem, 275, 26484-26491. Park, S., Myszka, D.G., Yu, M., Littler, S.J. and Laird-Offringa, I.A. (2000) HuD RNA recognition motifs play distinct roles in the formation of a stable complex with AU-rich RNA. Mol Cell Biol, 20, 4765-4772. Peng, S.S., Chen, C.Y., Xu, N. and Shyu, A.B. (1998) RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. Embo J, 17, 3461-3470. Phillips, K., Kedersha, N., Shen, L., Blackshear, P.J. and Anderson, P. (2004) Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis. Proc Natl Acad Sci U S A, 101, 2011-2016. Piecyk, M., Wax, S., Beck, A.R., Kedersha, N., Gupta, M., Maritim, B., Chen, S., Gueydan, C., Kruys, V., Streuli, M. and Anderson, P. (2000) TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. Embo J, 19, 4154-4163. Raghavan, A., Robison, R.L., McNabb, J., Miller, C.R., Williams, D.A. and Bohjanen, P.R. (2001) HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities. J Biol Chem, 276, 47958-47965. Ridley, S.H., Dean, J.L., Sarsfield, S.J., Brook, M., Clark, A.R. and Saklatvala, J. (1998) A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett, 439, 75-80. Robinow, S., Campos, A.R., Yao, K.M. and White, K. (1988) The elav gene product of Drosophila, required in neurons, has three RNP consensus motifs. Science, 242, 1570-1572. Rouse, J., Cohen, P., Trigon, S., Morange, M., Alonso-Llamazares, A., Zamanillo, D., Hunt, T. and Nebreda, A.R. (1994) A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell, 78, 1027-1037. Rutault, K., Hazzalin, C.A. and Mahadevan, L.C. (2001) Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha) mRNA induction. Evidence for selective destabilization of TNF-alpha transcripts. J Biol Chem, 276, 6666-6674. Sachs, A.B. (1993) Messenger RNA degradation in eukaryotes. Cell, 74, 413-421. Saklatvala, J. (2004) The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr Opin Pharmacol, 4, 372-377. Shim, J. and Karin, M. (2002) The control of mRNA stability in response to extracellular stimuli. Mol Cells, 14, 323-331. Stoeckle, M.Y. (1991) Post-transcriptional regulation of gro alpha, beta, gamma, and IL-8 mRNAs by IL-1 beta. Nucleic Acids Res, 19, 917-920. Stoecklin, G., Colombi, M., Raineri, I., Leuenberger, S., Mallaun, M., Schmidlin, M., Gross, B., Lu, M., Kitamura, T. and Moroni, C. (2002) Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover. Embo J, 21, 4709-4718. Stoecklin, G., Ming, X.F., Looser, R. and Moroni, C. (2000) Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway. Mol Cell Biol, 20, 3753-3763. Stoecklin, G., Stubbs, T., Kedersha, N., Wax, S., Rigby, W.F., Blackwell, T.K. and Anderson, P. (2004) MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. Embo J, 23, 1313-1324. Suk, K. and Erickson, K.L. (1996) Differential regulation of tumour necrosis factor-alpha mRNA degradation in macrophages by interleukin-4 and interferon-gamma. Immunology, 87, 551-558. Sully, G., Dean, J.L., Wait, R., Rawlinson, L., Santalucia, T., Saklatvala, J. and Clark, A.R. (2004) Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-element-binding protein 1). Biochem J, 377, 629-639. Tabara, H., Hill, R.J., Mello, C.C., Priess, J.R. and Kohara, Y. (1999) pos-1 encodes a cytoplasmic zinc-finger protein essential for germline specification in C. elegans. Development, 126, 1-11. Taylor, G.A., Carballo, E., Lee, D.M., Lai, W.S., Thompson, M.J., Patel, D.D., Schenkman, D.I., Gilkeson, G.S., Broxmeyer, H.E., Haynes, B.F. and Blackshear, P.J. (1996) A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity, 4, 445-454. Taylor, G.A., Lai, W.S., Oakey, R.J., Seldin, M.F., Shows, T.B., Eddy, R.L., Jr. and Blackshear, P.J. (1991) The human TTP protein: sequence, alignment with related proteins, and chromosomal localization of the mouse and human genes. Nucleic Acids Res, 19, 3454. Taylor, G.A., Thompson, M.J., Lai, W.S. and Blackshear, P.J. (1995) Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro. J Biol Chem, 270, 13341-13347. Taylor, G.A., Thompson, M.J., Lai, W.S. and Blackshear, P.J. (1996) Mitogens stimulate the rapid nuclear to cytosolic translocation of tristetraprolin, a potential zinc-finger transcription factor. Mol Endocrinol, 10, 140-146. Tchen, C.R., Brook, M., Saklatvala, J. and Clark, A.R. (2004) The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself. J Biol Chem, 279, 32393-32400. van der Giessen, K., Di-Marco, S., Clair, E. and Gallouzi, I.E. (2003) RNAi-mediated HuR depletion leads to the inhibition of muscle cell differentiation. J Biol Chem, 278, 47119-47128. Varnum, B.C., Lim, R.W., Sukhatme, V.P. and Herschman, H.R. (1989) Nucleotide sequence of a cDNA encoding TIS11, a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. Oncogene, 4, 119-120. Varnum, B.C., Ma, Q.F., Chi, T.H., Fletcher, B. and Herschman, H.R. (1991) The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual Cys-His repeat. Mol Cell Biol, 11, 1754-1758. Vasudevan, S. and Peltz, S.W. (2001) Regulated ARE-mediated mRNA decay in Saccharomyces cerevisiae. Mol Cell, 7, 1191-1200. Wang, W., Caldwell, M.C., Lin, S., Furneaux, H. and Gorospe, M. (2000) HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. Embo J, 19, 2340-2350. Wang, W., Furneaux, H., Cheng, H., Caldwell, M.C., Hutter, D., Liu, Y., Holbrook, N. and Gorospe, M. (2000) HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol, 20, 760-769. Wang, W., Yang, X., Cristofalo, V.J., Holbrook, N.J. and Gorospe, M. (2001) Loss of HuR is linked to reduced expression of proliferative genes during replicative senescence. Mol Cell Biol, 21, 5889-5898. Wilson, G.M. and Brewer, G. (1999) Identification and characterization of proteins binding A + U-rich elements. Methods, 17, 74-83. Wilusz, C.J., Wormington, M. and Peltz, S.W. (2001) The cap-to-tail guide to mRNA turnover. Nat Rev Mol Cell Biol, 2, 237-246. Winzen, R., Gowrishankar, G., Bollig, F., Redich, N., Resch, K. and Holtmann, H. (2004) Distinct domains of AU-rich elements exert different functions in mRNA destabilization and stabilization by p38 mitogen-activated protein kinase or HuR. Mol Cell Biol, 24, 4835-4847. Winzen, R., Kracht, M., Ritter, B., Wilhelm, A., Chen, C.Y., Shyu, A.B., Muller, M., Gaestel, M., Resch, K. and Holtmann, H. (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. Embo J, 18, 4969-4980. Worthington, M.T., Amann, B.T., Nathans, D. and Berg, J.M. (1996) Metal binding properties and secondary structure of the zinc-binding domain of Nup475. Proc Natl Acad Sci U S A, 93, 13754-13759. Worthington, M.T., Pelo, J.W., Sachedina, M.A., Applegate, J.L., Arseneau, K.O. and Pizarro, T.T. (2002) RNA binding properties of the AU-rich element-binding recombinant Nup475/TIS11/tristetraprolin protein. J Biol Chem, 277, 48558-48564. Xu, N., Chen, C.Y. and Shyu, A.B. (1997) Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay. Mol Cell Biol, 17, 4611-4621. Xu, N., Chen, C.Y. and Shyu, A.B. (2001) Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover. Mol Cell Biol, 21, 6960-6971. Xu, N., Loflin, P., Chen, C.Y. and Shyu, A.B. (1998) A broader role for AU-rich element-mediated mRNA turnover revealed by a new transcriptional pulse strategy. Nucleic Acids Res, 26, 558-565. Yu, H., Stasinopoulos, S., Leedman, P. and Medcalf, R.L. (2003) Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin. J Biol Chem, 278, 13912-13918. Zhang, W., Wagner, B.J., Ehrenman, K., Schaefer, A.W., DeMaria, C.T., Crater, D., DeHaven, K., Long, L. and Brewer, G. (1993) Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol Cell Biol, 13, 7652-7665. Zhu, W., Downey, J.S., Gu, J., Di Padova, F., Gram, H. and Han, J. (2000) Regulation of TNF expression by multiple mitogen-activated protein kinase pathways. J Immunol, 164, 6349-6358. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35983 | - |
| dc.description.abstract | 訊息RNA的穩定性是真核細胞調控基因表現的一個主要機制，因而影響細胞的生長和分化。AU-rich elements (AREs)位在許多原致癌基因、細胞激素以及一些生長因子的mRNA之3’untranslated regions當中，可能是使它們自己的mRNAs快速降解的目標序列。HuR是RNA結合蛋白當中ELAV family的一個成員，它的表現非常廣泛；在短暫轉殖的細胞，HuR會結合到AREs上，並且使含有ARE的mRNAs變的穩定。Tristetraproline（TTP）是一個immediate-early gene，它可以結合到AREs引起RNA的不穩定。為了要研究ARE-containing mRNAs穩定性的調控機制，因此我們在LPS刺激的巨噬細胞中，完成了TNFα和IL-1β mRNAs半衰期的表現和調控機制的實驗。泳動阻滯電泳分析（EMSA）顯示由LPS誘導的去穩定因子TTP可以以較高的親和力結合到TNFα ARE上，而對IL-1β ARE的親和力則較低。HuR被發現可以和TNFα ARE相互作用來穩定它的RNA。有趣的是，由LPS誘導的IL-1β mRNA穩定性是p38 signaling pathway-dependent，而TNFα mRNA的穩定性則是p38 signaling pathway-independent。p38 pathway的活化導致TTP磷酸化並且降低它和RNA結合的活性。相對於TNFα的ARE，p38的訊息可以取消TTP在IL-1β ARE上的抑制作用。我們的結果指出TTP可以反應p38的訊號來調節IL-1β等ARE-containing mRNA的表現。 | zh_TW |
| dc.description.abstract | Messenger RNA stability is one of the key mechanisms that eukaryotic cells regulate gene expression and influence cell growth and differentiation. AU-rich elements (AREs) present in the 3’ untranslated regions of mRNAs from many protooncogenes, cytokines, and growth factors may be targets for rapid degradation. HuR, a ubiquitous expressed member of the ELAV family of RNA binding proteins, selectively binds to AREs and stabililizes ARE-containing mRNAs in transiently transfected cells. Tristetraproline (TTP) is an immediate-early gene that could bind to AREs and trigger RNA destabilization. To investigate the regulation of stability of ARE-containing mRNAs, we performed experiments on the expression and regulation of half-life of TNFα and IL-1β mRNAs in LPS-stimulated macrophages. Electrophoretic mobility shift assays showed that the LPS-induced destabilization factor TTP could bind to TNFα ARE much better than that of IL-1β ARE. HuR was found to interact with TNFα ARE to stabilize its RNA. Interestingly, LPS-induced stability of IL-1β mRNA was p38 signaling pathway-dependent while that of TNFα mRNA was p38 signaling pathway-independent. Activation of p38 pathway resulted in the phosphorylation of TTP and decrease of its RNA-binding activity. Contrary to ARE of TNFα, p38 signal could reverse the inhibitory activity of TTP on IL-1β ARE. Our results indicate that TTP could respond to p38 signal to modulate the expression of specific ARE-containing mRNAs such as IL-1β. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T07:49:08Z (GMT). No. of bitstreams: 1 ntu-94-R91242001-1.pdf: 1846292 bytes, checksum: e721a00fb59333c8b82595f7ba7300a1 (MD5) Previous issue date: 2005 | en |
| dc.description.tableofcontents | 目錄
中文摘要............................................................................................................1 Abstract.............................................................................................................2 第一章：前言.....................................................................................................3 1. AU-rich element-containing mRNAs..................................................................3 2. RNA-binding protein......................................................................................6 2.1 Hu-antigen R（HuR）...................................................................................8 2.2 Tristetraprolin（TTP）.................................................................................10 3. p38 Mitogen-activated protein kinase（MAPK） pathway.................................13 第二章: 材料與方法.........................................................................................17 1. 質體建構....................................................................................................17 1.1 HuR cDNA和TTP cDNA...............................................................................17 1.2 TNFα cDNA和IL-1β cDNA............................................................................17 1.3 TNFα ARE和IL-1β ARE...............................................................................18 1.4 其他的質體.................................................................................................18 2. 細胞培養......................................................................................................18 3. Total RNA Isolation......................................................................................19 4. Reverse Transcription-Polymerase Chain Reaction..........................................19 4.1 Reverse Transcription.................................................................................20 4.2 聚合脢鏈鎖反應.........................................................................................20 5. 細胞質及細胞核萃取物抽取............................................................................23 6. SDS 聚丙烯醯胺膠體電泳.............................................................................23 7. SDS-PAGE染色法........................................................................................24 8. 西方墨點分析................................................................................................24 9. RNA泳動阻滯電泳分析..................................................................................25 9.1 RNA探針製備.............................................................................................25 9.2 RNA泳動阻滯電泳分析.................................................................................27 10. 轉接載體....................................................................................................28 11. DH5α轉型..................................................................................................28 12. GST 融合蛋白質.........................................................................................29 12.1 GST融合蛋白質誘導表現............................................................................29 12.2純化GST融合蛋白質...................................................................................29 13. 抗體..........................................................................................................30 14. 質體抽取....................................................................................................30 14.1小量質體抽取.............................................................................................30 14.2大量質體抽取.............................................................................................31 15. 細胞轉殖.....................................................................................................31 15.1.磷酸鈣細胞轉殖.........................................................................................31 15.2以Lipofectamine 2000進行細胞轉殖..............................................................32 16. 冷光酵素活性分析.......................................................................................33 16.1 β-gal for normalize....................................................................................33 16.2 Luciferase assay.......................................................................................34 第三章: 實驗結果..............................................................................................35 實驗安排.........................................................................................................35 1. TNFα mRNA及IL-1β mRNA在受LPS刺激的巨噬細胞內表現的情況.....................36 2. 3’UTR對TNFα和IL-1β mRNA表現的影響.......................................................37 3. TTP蛋白質及HuR蛋白質在受LPS刺激的巨噬細胞內表現的情況.........................38 4. HuR及TTP和TNFα ARE的連結能力................................................................38 5. HuR及TTP和IL-1β ARE的連結能力.................................................................39 6. 重組TTP蛋白質和ARE的結合能力..................................................................40 7. 重組HuR蛋白質的各個RNA recognition motif和ARE的結合能力.........................41 8. HuR和TTP對TNFα及IL-1β表現的調控機制.......................................................42 9. p38 MAPK pathway對LPS誘導的RNA穩定性及TTP表現的影響.........................43 10.p38 MAPK pathway對TTP、HuR表現及Luc-ARE活性的影響............................44 第四章：討論...................................................................................................47 參考文獻.........................................................................................................54 圖表與附錄......................................................................................................67 圖1 TNFα mRNA及IL-1β mRNA在受LPS刺激的巨嗜細胞內表現的情況.................68 圖2 3’UTR對TNFα和IL-1β mRNA表現的影響....................................................70 圖3 TTP蛋白質及HuR蛋白質在受LPS刺激的巨嗜細胞內表現的情況......................72 圖4 HuR及TTP和TNFα ARE的連結能力.............................................................73 圖5 HuR及TTP和IL-1β ARE的連結能力..............................................................74 圖6 重組TTP蛋白質和ARE的結合能力...............................................................75 圖7 重組HuR蛋白質的各個RNA recognition motif和ARE的結合能力......................76 圖8 HuR和TTP對TNFα及IL-1β表現的調控機制.....................................................77 圖9 p38 MAPK pathway對LPS誘導的RNA穩定性及TTP表現的影響......................79 圖10 p38 MAPK pathway對TTP、HuR表現及Luc-ARE活性的影響........................80 附錄1 各種mRNA 3’UTR中ARE的特色比較.......................................................83 附錄2 三類ARE的序列及功能特性.......................................................................83 附錄3 ARE-mRNAs的生物多樣性.......................................................................84 附錄4 mRNA降解方式.......................................................................................85 附錄5 各種ARE-BPs的特色................................................................................86 附錄6 HuR的胺基酸序列...................................................................................87 附錄7 TTP的胺基酸序列.....................................................................................87 附錄8 p38 MAPK抑制劑：SB203580..................................................................88 附錄9 Mitogen-activated protein kinase signaling pathways...................................88 縮寫表.............................................................................................................89 | |
| dc.language.iso | zh-TW | |
| dc.subject | RNA結合蛋白 | zh_TW |
| dc.subject | 細胞激素 | zh_TW |
| dc.subject | 穩定性 | zh_TW |
| dc.subject | stability | en |
| dc.subject | RNA binding protein | en |
| dc.subject | cytokine | en |
| dc.title | 巨噬細胞中RNA結合蛋白HuR和TRISTETRAPROLINE對細胞激素RNA穩定性的調控之研究 | zh_TW |
| dc.title | REGULATION OF CYTOKINE mRNA STABILITY BY ARE-BINDING PROTEINS HuR AND TRISTETRAPROLINE IN MACROPHAGES | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 93-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 呂勝春,李玉梅,譚婉玉 | |
| dc.subject.keyword | 細胞激素,穩定性,RNA結合蛋白, | zh_TW |
| dc.subject.keyword | cytokine,stability,RNA binding protein, | en |
| dc.relation.page | 90 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2005-07-26 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 生化科學研究所 | zh_TW |
| 顯示於系所單位： | 生化科學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-94-1.pdf 未授權公開取用 | 1.8 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。